Cancer Antigen 72-4 (CA 72-4)
CA 72-4 is a tumor marker used to monitor the progression and treatment response of gastric and ovarian cancers.
CA 72-4 is a biomarker for monitoring gastric and ovarian cancers.
Key facts at a glance
- Units
- U/mL
- Clinical utility
- monitoring
- Result kind
- quantitative
- FDA-cleared
- Roche CA 72-4, Abbott CA 72-4, Fujirebio CA 72-4
Cancer Antigen 72-4 (CA 72-4) is a glycoprotein that is often elevated in patients with gastric and ovarian cancers. It is primarily used to monitor the effectiveness of treatment and to detect recurrence of these cancers.
The normal reference range for CA 72-4 is typically between 0–6.9 U/mL. Elevated levels may indicate the presence of cancer or the need for further diagnostic evaluation.
While CA 72-4 is not recommended as a screening tool due to its lack of sensitivity and specificity, it is valuable for monitoring disease progression and treatment response in diagnosed patients.
Frequently asked questions
What is the primary use of CA 72-4?
Can CA 72-4 be used for cancer screening?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy